In a report released on February 7, Kevin Heal from Argus Research maintained a Buy rating on Raymond James Financial (RJF – Research Report). The company’s shares closed last Friday at $167.43.

Lower interest rates over the next several years will stifle net interest income growth. The company may have a greater opportunity to recruit advisors as it fills holes in its geographic footprint ...

"It's part of the environment. It's part of life." Meanwhile at the UBS Financial Services Conference in Key Biscayne, Florida, Raymond James President Paul Shoukry likewise expressed a lack of ...

Stock analysts at Raymond James lowered their FY2025 EPS estimates for shares of Canaccord Genuity Group in a report issued ...

From security to development, the wealth management firm uses the Dynatrace platform to give senior executives information on ...

On Monday, Raymond (NSE:RYMD) James maintained a Market Perform rating on Cerence Inc . (NASDAQ:CRNC) shares, reflecting a steady outlook after the company's recent financial performance.

Additionally, Hess's operating costs were 7% below Raymond James's estimates. The company's strong performance is reflected in its impressive P/E ratio of 16x and "GREAT" financial health score ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

James maintained a positive outlook on Q2 Holdings (NYSE: NYSE:QTWO) shares, as analyst Alexander Sklar increased the price target from $100.00 to $110.00 while reaffirming an Outperform rating. The ...